Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
11
|
| pubmed:dateCreated |
1992-6-4
|
| pubmed:abstractText |
Although malignant mesothelioma is a relatively rare tumor, its incidence is rising. Much of the increase is attributable to widespread exposure to asbestos in past decades in asbestos-related industries. In recent years, it has become increasingly clear that mesothelioma risk is no longer confined to workers in the asbestos industry. This article reports a variety of recently identified "risk groups" and highlights the need for increased surveillance of these groups to document the occurrence of asbestos-related malignancy and the institution of measures for disease prevention.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0008-543X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
69
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2704-11
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading | |
| pubmed:year |
1992
|
| pubmed:articleTitle |
Changing risk groups for malignant mesothelioma.
|
| pubmed:affiliation |
Massachusetts General Hospital, Harvard Medical School, Boston.
|
| pubmed:publicationType |
Journal Article
|